Heidelberg Pharma AG (ETR:HPHA)
4.380
+0.060 (1.39%)
Aug 22, 2025, 5:35 PM CET
Heidelberg Pharma AG Employees
Heidelberg Pharma AG had 105 employees as of November 30, 2024. The number of employees increased by 10 or 10.53% compared to the previous year.
Employees
105
Change (1Y)
10
Growth (1Y)
10.53%
Revenue / Employee
€37,687
Profits / Employee
€209,980
Market Cap
204.13M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Nov 30, 2024 | 105 | 10 | 10.53% |
Nov 30, 2023 | 95 | -7 | -6.86% |
Nov 30, 2022 | 102 | 13 | 14.61% |
Nov 30, 2021 | 89 | 11 | 14.10% |
Nov 30, 2020 | 78 | 8 | 11.43% |
Nov 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Nov 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Nov 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Nov 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Nov 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
Siemens Healthineers AG | 72,000 |
Merck KGaA | 59,020 |
Bayer Aktiengesellschaft | 91,864 |
Fresenius SE & Co. KGaA | 176,486 |
Fresenius Medical Care AG | 111,513 |
Sartorius Aktiengesellschaft | 13,528 |
Fielmann Group AG | 24,363 |
Carl Zeiss Meditec AG | 5,730 |
Heidelberg Pharma AG News
- 24 days ago - EQS-NVR: Heidelberg Pharma AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution - Wallstreet:Online
- 4 weeks ago - EQS-DD: Heidelberg Pharma AG: Prof. Dr. Andreas Pahl, Acquisition of 90,000 shares through the exercise of 90,000 stock options under the 2011 stock option program (tranche 2; issue 2016) for ... - Wallstreet:Online
- 6 weeks ago - EQS-News: Heidelberg Pharma Reports on First Half-Year 2025 and the Positive Course of Business - Wallstreet:Online
- 3 months ago - EQS-News: Heidelberg Pharma Reports on the Results of the Ordinary Annual General Meeting 2025 and New Supervisory Board - Wallstreet:Online
- 3 months ago - EQS-News: Heidelberg Pharma to Present Promising New Clinical Data on its Lead ATAC Candidate HDP-101 at EHA 2025 - Wallstreet:Online
- 4 months ago - EQS-News: Heidelberg Pharma AG: Interim Statement on the First Three Months of Financial Year 2025 - Wallstreet:Online
- 5 months ago - EQS-News: Heidelberg Pharma to Present Data from its ADC Technology Platforms at AACR Annual Meeting 2025 - Wallstreet:Online
- 5 months ago - Heidelberg Pharma AG (XTER:HPHA) Full Year 2024 Earnings Call Highlights: Navigating Financial ... - GuruFocus